China PharmaHub Corp. Signs Major 5-Year Agreement

BOSTON, July 15 /PRNewswire/ -- China PharmaHub Corp. ("PharmaHub"), the majority owner of World Wide Relics, Inc. (OTC Bulletin Board: WRLC), announced today that it has entered into a five-year Cooperation Agreement ("Agreement") with the Sichuan Technical Exchange Center ("STEC"), a subsidiary of the Sichuan Provincial Science & Technology Department.  PharmaHub will represent the Sichuan government in seeking out biotechnology projects and the STEC will be assisting PharmaHub and its partners in executing business ventures in Sichuan. The Agreement entails a strategic partnership in the bio-pharmaceutical and medical device industries to promote technological exchange and transfer between China and the US through the relationship between PharmaHub and the STEC.  

PharmaHub is engaged in the business of licensing, development and commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe.  The Sichuan Technical Exchange Center is a major professional institution under the Sichuan Provincial Government tasked with carrying out international technological exchange and transfer projects in Sichuan.  Sichuan Province, a booming economic hub of 81 million people with a 2009 annual GDP of $207 billion USD and powered by over $1.8 billion a year in domestic and foreign investments, has developed into a modern hi-tech industrial base for information technology and pharmaceuticals.

"We are thrilled with this opportunity. The Agreement with the Sichuan Technical Exchange Center represents a strategic opportunity for PharmaHub and its shareholders to increase awareness of PharmaHub while building relationships with existing as well as potential future pharmaceutical partners," stated Richard Lui, CEO of PharmaHub.  "This is another successful demonstration of our HUB model. This partnership represents a milestone in PharmaHub's drive to become a leader in the pharmaceutical and medical device industry."

Mr. Cai, Director of the Sichuan Technical Exchange Center said, "We are very pleased to be working with PharmaHub.  The Sichuan Provincial Government attaches great importance to international technology transfer, especially in the areas of biotechnology, healthcare and alternative energy. By establishing this partnership, both the STEC and PharmaHub each gain a strong partner and the strategic ability to expand our market presence."

The Agreement has both sides agreeing to jointly establish the technical exchange transfer service platform and the STEC will coordinate with the Sichuan Provincial Government to ensure the signed technology transfer projects gain government support in policy making, strategic technological cooperation, and financing. According to the statistics report of the Sichuan Pharmaceutical Industry Association, Sichuan has over 396 pharmaceutical manufacturers and over 18,629 companies focusing on the sales and marketing of medicine and medical equipment in 2009 and an industrial output of 49.7 billion RMB ($7.2 billion USD). In recent years, Sichuan has made significant investments in furthering biotechnology, new drug discovery and healthcare.

Mr. Lui continued, "We will immediately begin providing bio-pharmaceutical and medical device technology transfer projects to businesses and the Sichuan government. PharmaHub plans to introduce over 30 projects in bio-pharmaceutical and medical devices as well as co-sponsor conferences with the STEC to facilitate the execution of these projects. The Agreement also opens up significant strategic opportunities for PharmaHub to meet with pharmaceutical and medical device companies and explore possible business ventures."  

About PharmaHub:

China PharmaHub Corp. is engaged in the business of licensing, developing and the commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe. Management believes that PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality.  PharmaHub's corporate headquarters are located in California, with offices in Boston and China.

About World Wide Relics:

World Wide Relics, Inc. produces and markets historical costumes and reenactment clothing lines. The company sells its products to the enthusiasts and collectors on e-stores, such as Ebay.com. World Wide Relics, Inc. was founded in 2005 and is based in New York, New York.

Forward-Looking Statements

This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein.

SOURCE China PharmaHub Corp.